Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $102.8000 (-0.88%) ($102.0100 - $103.5000) on Tue. Dec. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.79% (three month average) | RSI | 46 | Latest Price | $102.8000(-0.88%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(45%) SPLV(36%) VYM(33%) XLP(33%) DIA(32%) | Factors Impacting ABBV price | ABBV will decline at least -0.895% in a week (0% probabilities). VIXM(-23%) UUP(-10%) VXX(-5%) IGOV(-2%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.895% (StdDev 1.79%) | Hourly BBV | -0.7 () | Intraday Trend | -0.6% | | | |
|
Resistance Level | $105.1 | 5 Day Moving Average | $104.1(-1.25%) | 10 Day Moving Average | $104.91(-2.01%) | 20 Day Moving Average | $105.1(-2.19%) | To recent high | -5.4% | To recent low | 27.7% | Market Cap | $181.368b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |